JosephPaulEderMD

Clinical Trials

• Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid Tumors Start of enrollment: 1999 Aug 01

  Completed

  Phase 1

• Vaccine Therapy in Treating Patients With Advanced Adenocarcinoma of the Prostate (Prostate Cancer) Start of enrollment: 2000 Jan 01

  Terminated

  Phase 2

• BMS-214662 in Treating Patients With Advanced Solid Tumors Start of enrollment: 2000 Jul 01

  Completed

  Phase 1

• KRN5500 in Treating Patients With Solid Tumors Start of enrollment: 2002 Feb 01

  Completed

  Phase 1

• Vaccine Therapy in Treating Patients With Metastatic Breast Cancer Start of enrollment: 2003 Oct 01

  Terminated

  Phase 1

• Safety Study of PT-523 in Cancer Patients to Treat Solid Tumors Including a Preliminary Assessment of Effectiveness Start of enrollment: 2004 Mar 01

  Terminated

  Phase 1

• Talotrexin in Treating Patients With Advanced or Recurrent Solid Tumors Start of enrollment: 2003 Dec 01

  Completed

  Phase 1

• Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function Start of enrollment: 2011 Nov 01

  Completed

  Phase 1

• Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced Malignancies Start of enrollment: 2013 Mar 01

  Completed

  Phase 1, Phase 2

• A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of KTN3379 in Adult Subjects With Advanced Tumors Start of enrollment: 2014 Jan 01

  Completed

  Phase 1

• LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE) Start of enrollment: 2014 Aug 25

  Completed

  Phase 2

• First-in-Human Study of MS201408-0005A as Single Agent and in Combinations Start of enrollment: 2017 Oct 03

  Terminated

  Phase 1

• Join now to see all